J&J
As on 13 Oct, 2025 | 21:58 IST
| Open | 189.83 |
| Previous Close | 190.72 |
| Beta | -0.02 |
| High | 191.01 |
| Low | 189.32 |
| TTM EPS See historical trend | 10.00(-4.58% YoY) |
| 52 Week High | 192.07 |
| 52 Week Low | 141.30 |
| TTM PE See historical trend | 19.03(High PE) |
| Mkt. Cap ($ Billion) | 458.46 |
| Dividend Yield | 3.29 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 190.16 |
| 10 | 188.5 |
| 20 | 182.78 |
| 50 | 178.78 |
| 100 | 168.11 |
| 200 | 161.3 |
Returns
| 1 Week | 1.11% | |
| 1 Month | 6.83% | |
| 3 Months | 21.29% | |
| YTD | 31.63% | |
| 1 Year | 17.91% | |
| 3 Years | 15.16% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | 833.49 | -2.56 | 792.18 | 51.59 | 16.15 | 0.74 | 935.37/623.99 | 10.39 | Very Bullish |
| J&J | 190.25 | -0.25 | 458.46 | 19.03 | 10.00 | 3.29 | 192.07/141.30 | 6.83 | Very Bullish |
| AbbVie | 230.54 | -0.07 | 407.43 | 21.77 | 10.59 | 3.49 | 244.80/163.83 | 8.94 | Very Bullish |
| Abbott | 132.58 | -0.55 | 229.94 | 27.06 | 4.90 | 1.71 | 141.07/110.89 | 2.47 | Bearish |
| Merck | 85.79 | -0.23 | 217.28 | 11.23 | 7.64 | 4.04 | 111.57/73.35 | 3.60 | Bullish |
Market news
- Dow, S&P 500 manage record closing highs; Nasdaq falls in volatile sessionOctober 4, 2025 9:34 AM
- Wall Street closes higher, boosted by healthcare as investors shrug off jobs data, US shutdownOctober 2, 2025 8:05 AM
- Wall Street ends streak of weekly gains, yields rise as investors digest dataSeptember 27, 2025 8:50 AM
- Stocks finish week higher; Wall Street at record highsSeptember 20, 2025 7:43 AM
About the company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.